HOME >> BIOLOGY >> NEWS
Lipid plays big role in embryonic development

A little-known lipid plays a big role in helping us grow from a hollow sphere of stem cells into human beings, researchers have found.

They found that in the first few days of life, ceramide helps stem cells line up to form the primitive ectoderm from which embryonic tissues develop, says Dr. Erhard Bieberich, biochemist at the Medical College of Georgia.

Probably 90 percent of ceramide gathers at the top or apical end of these early stem cells, literally helping cells have direction. "We have cell polarity, an up and down, a head and foot of the cell, and that is what ceramide most likely regulates," says Dr. Bieberich. "Cell polarity is absolutely essential for differentiation; otherwise you have a ball of cells, not organized tissue."

In fact, we start out as a wad of cells, but within 24 hours, some cells die and others become part of the hollow sphere with an inner layer -- the primitive ectoderm -- that will further differentiate into an embryo, and an outer layer -- the primitive endoderm -- that sustains the embryo during development.

"Ceramide distributes to the apical end of the cell," says Kannan Krishnamurthy, MCG graduate student and first author of the study published in the Feb. 2 issue of the Journal of Biological Chemistry. "In this case, the basal end, or lower end, is attached to the outer layer while the apical end points toward the sphere's cavity."

Cells make ceramide, which researchers are finding has many different jobs in the developing and mature body. Like other lipids, it helps make up membranes throughout the body, it has an insulation role in the skin and it is a precursor for the protective coating of nerves, called myelin.

"There is more and more evidence that ceramide not only is a structural lipid but a messenger involved in signal transduction, in telling proteins what to do," says Dr. Guanghu Wang, MCG research assistant scientist who shares first authorship.'"/>

Contact: Toni Baker
tbaker@mcg.edu
706-721-4421
Medical College of Georgia
2-Feb-2007


Page: 1 2

Related biology news :

1. Story ideas from the Journal of Lipid Research
2. Story ideas from the Journal of Lipid Research
3. Beyond genes: Lipid helps cell wall protein fold into proper shape
4. Lipids get new comprehensive classification system
5. Ethnicity plays a role in neonatal deaths
6. Research study describes the role part of the brain plays in memory
7. Clock gene plays role in weight gain, study finds
8. Researchers identify gene that plays key role in size of dogs
9. Motor protein plays key role in connecting neurons
10. Study identifies glucose sensor that plays dual role in glucose metabolism and fat synthesis
11. Fish species plays surprise role in aiding coral reef recovery

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Lipid plays big role embryonic development

(Date:7/2/2015)... Fingerprint Cards has received an order for its ... distributor World Peace Industrial Group (WPI), part of WPG Holdings. ... . Deliveries are planned to take place during Q3 ... manufacturers in Asia . The order value ... of approximately 2,200 MSEK for 2015. Jörgen Lantto, ...
(Date:6/30/2015)... Genisphere announced Tom Bliss ... further develop Genisphere,s therapeutics capabilities and portfolio. Mr. Bliss ... much of the last 25 years in leadership positions ... Johnson & Johnson. Tom started his career in Investment ... Finance. He graduated from Dartmouth College with a BA ...
(Date:6/26/2015)... , June 26, 2015 ATL Technology, LLC, a ... with specialties in single use solutions, headquartered in ... Inc. (a California corporation with locations ... San Jose, Costa Rica ). This ... Rica with ATL Technology,s existing facility in ...
Breaking Biology News(10 mins):FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2
(Date:7/3/2015)... Forskare kan ansöka ... http://www.openinnovationinscience.at till det återkommande utbildningsprogrammet "Lab ... i Wien .  ... forskare och vetenskapsmän som genomfördes av Ludwig ... utmaningar bristen på incitament för att undersöka ...
(Date:7/2/2015)... GLEN ELLYN, Ill. , July 2, 2015 /PRNewswire-USNewswire/ ... and Colton Eakins are gaining invaluable real-world ... Institute of Technology this summer. The students ... Dr. Jeff Wereszczynski,s research group at IIT. ... Professors Dr. Tom Carter , Physics; Dr. ...
(Date:7/1/2015)... ... 2015 , ... It is now possible to separate two common disorders: post-traumatic ... tomography (SPECT) according to researchers from Amen Clinics, UCLA, Thomas Jefferson University, and ... is believed to be the largest brain imaging study ever, will be published on ...
(Date:7/1/2015)... 2015   Neuraltus Pharmaceuticals, Inc. , a privately-held ... drugs to treat neurodegenerative diseases such as amyotrophic ... G. Miller , M.D., Director of the Forbes Norris ... Medical Center in San Francisco, has been awarded a ... to help fund a Phase 2 clinical study ...
Breaking Biology Technology:Lansering av världens första program för öppen innovation för att utbilda forskare 2Lansering av världens första program för öppen innovation för att utbilda forskare 3COD Students Participate in Prestigious Summer Internships 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 4Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4
Cached News: